LENSAR, Inc. (LNSR) Financials

LNSR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 66.2 million 41.6 million
Dec. 31, 2025 71.4 million 97.4 million
Sept. 30, 2025 70.2 million 82.3 million
June 30, 2025 70.4 million 79.7 million

LNSR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.3 million 690000
Dec. 31, 2025 618000 873000
Sept. 30, 2025 -3.5 million 850000
June 30, 2025 -5.1 million 766000

LNSR Net Income

No data available :(

LNSR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 13.5 million - 1.8 million
Dec. 31, 2025 18.0 million - 2.7 million
Sept. 30, 2025 16.9 million - 2.9 million
June 30, 2025 20.3 million - 2.3 million

LNSR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 15.4 million
Dec. 31, 2025 12.1 million
Sept. 30, 2025 12.0 million
June 30, 2025 11.9 million

LNSR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.4 million 2.5 million -
Dec. 31, 2025 - 1.3 million 10.3 million -
Sept. 30, 2025 - 1.4 million 12.0 million -
June 30, 2025 77000 1.4 million 11.7 million -

LNSR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 13.4 million 7.0 million
Dec. 31, 2025 16.0 million 9.1 million
Sept. 30, 2025 14.3 million 8.5 million
June 30, 2025 13.9 million 6.9 million

LNSR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LNSR

Price: $5.74

52 week price:
5.06
13.67

Payout Ratio Range:
-37.06%
-0.82%

Earnings Per Share: -0.55 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 3193

Market Capitalization: 67.8 million

Links: